JENNIFER LECONTE: Open Payments
NPI 1801268826 · SOMERSET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,816 in 84 payments from 26 companies in 2025. Trend: 2023 $142 · 2024 $352 · 2025 $2,816
Food & beverage: $1,472Travel & lodging: $1,344
| Company | Payments | Amount |
|---|---|---|
| MicroTransponder, Inc. | 3 | $1,488 |
| UCB, Inc. | 16 | $260 |
| Neurelis, Inc. | 11 | $152 |
| Teva Pharmaceuticals USA, Inc. | 7 | $112 |
| ABBVIE INC. | 5 | $77 |
| Tanabe Pharma America, Inc. | 4 | $69 |
| ARGENX US, INC. | 4 | $67 |
| JAZZ PHARMACEUTICALS INC. | 4 | $67 |
| SERVIER PHARMACEUTICALS LLC | 3 | $55 |
| Neurocrine BioSciences, Inc. | 3 | $54 |
Products named: VALTOCO, Briviact, AUSTEDO XR, Radicava, EPIDIOLEX, Rystiggo, Nayzilam, INGREZZA.
Industry payments across NJ — which companies pay providers there.
